1. Home
  2. EPSN vs KPTI Comparison

EPSN vs KPTI Comparison

Compare EPSN & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.81

Market Cap

132.1M

Sector

Energy

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.38

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSN
KPTI
Founded
2005
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.1M
172.6M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
EPSN
KPTI
Price
$5.81
$8.38
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.50
AVG Volume (30 Days)
214.4K
616.4K
Earning Date
03-24-2026
02-12-2026
Dividend Yield
4.31%
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
$41.35
N/A
Revenue Next Year
N/A
$46.62
P/E Ratio
$19.35
N/A
Revenue Growth
N/A
0.57
52 Week Low
$4.20
$3.51
52 Week High
$8.50
$10.99

Technical Indicators

Market Signals
Indicator
EPSN
KPTI
Relative Strength Index (RSI) 66.39 49.01
Support Level $4.62 $5.60
Resistance Level $5.98 $8.95
Average True Range (ATR) 0.22 0.73
MACD 0.03 -0.17
Stochastic Oscillator 87.63 41.91

Price Performance

Historical Comparison
EPSN
KPTI

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: